Genetic Technologies (NASDAQ:GENE) Stock Price Crosses Above Two Hundred Day Moving Average of $1.39

Genetic Technologies Limited (NASDAQ:GENE)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.39 and traded as high as $1.82. Genetic Technologies shares last traded at $1.78, with a volume of 6,863 shares trading hands.

Separately, ValuEngine raised Genetic Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, September 4th.

The firm has a fifty day moving average of $1.98 and a two-hundred day moving average of $1.39.

Genetic Technologies Company Profile (NASDAQ:GENE)

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage the women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer.

See Also: What is the CBOE Russell 2000® Volatility Index?

Receive News & Ratings for Genetic Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genetic Technologies and related companies with's FREE daily email newsletter.